235 related articles for article (PubMed ID: 18830571)
1. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.
Balakumar P; Chakkarwar VA; Singh M
Mol Cell Biochem; 2009 Jan; 320(1-2):149-62. PubMed ID: 18830571
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
Chakkarwar VA
Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
[TBL] [Abstract][Full Text] [Related]
3. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
Balakumar P; Sharma R; Singh M
Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
[TBL] [Abstract][Full Text] [Related]
4. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction.
Verma S; Reddy K; Balakumar P
Biol Trace Elem Res; 2010 Oct; 137(1):96-109. PubMed ID: 19943121
[TBL] [Abstract][Full Text] [Related]
5. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
Kaur J; Reddy K; Balakumar P
Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
[TBL] [Abstract][Full Text] [Related]
6. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Bishnoi HK; Mahadevan N; Balakumar P
Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
[TBL] [Abstract][Full Text] [Related]
7. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
Arora MK; Reddy K; Balakumar P
Eur J Pharmacol; 2010 Jun; 636(1-3):137-44. PubMed ID: 20347778
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.
Balakumar P; Varatharajan R; Nyo YH; Renushia R; Raaginey D; Oh AN; Akhtar SS; Rupeshkumar M; Sundram K; Dhanaraj SA
Pharmacol Res; 2014 Dec; 90():36-47. PubMed ID: 25263930
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
Kadian S; Mahadevan N; Balakumar P
Eur J Pharmacol; 2013 Jan; 698(1-3):388-96. PubMed ID: 23085026
[TBL] [Abstract][Full Text] [Related]
10. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
Bhardwaj P; Khanna D; Balakumar P
Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia.
Arora MK; Sarup Y; Tomar R; Singh M; Kumar P
J Diet Suppl; 2019; 16(2):227-244. PubMed ID: 29621403
[TBL] [Abstract][Full Text] [Related]
12. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
Kaur T; Goel RK; Balakumar P
Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
Shah DI; Singh M
Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
Nirwane A; Pawar V; Majumdar A
J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
Kathuria S; Mahadevan N; Balakumar P
Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
[TBL] [Abstract][Full Text] [Related]
17. Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signals.
Taneja G; Mahadevan N; Balakumar P
Cardiovasc Toxicol; 2013 Jun; 13(2):110-22. PubMed ID: 23208382
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative potential of angiotensin1-7/Mas receptor axis in streptozotocin-induced diabetic nephropathy in rats.
Singh T; Singh K; Sharma PL
Methods Find Exp Clin Pharmacol; 2010; 32(1):19-25. PubMed ID: 20383342
[TBL] [Abstract][Full Text] [Related]
19. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats.
Shah DI; Singh M
Mol Cell Biochem; 2007 Jan; 295(1-2):65-74. PubMed ID: 16841179
[TBL] [Abstract][Full Text] [Related]
20. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
Jindal S; Singh M; Balakumar P
Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
